SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-018533
Filing Date
2020-04-24
Accepted
2020-04-24 16:27:56
Documents
3
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A myok-defa14a_20200618.htm DEFA14A 113729
2 GRAPHIC gw23gddrrhrp000001.jpg GRAPHIC 16555
3 GRAPHIC gw23gddrrhrp000002.jpg GRAPHIC 3336
  Complete submission text file 0001564590-20-018533.txt   142492
Mailing Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Business Address 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 650-741-0900
MyoKardia, Inc. (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37609 | Film No.: 20815424
SIC: 2834 Pharmaceutical Preparations